Sotalol oral solution - Arbor Pharmaceuticals

Drug Profile

Sotalol oral solution - Arbor Pharmaceuticals

Alternative Names: AR05; Sotalol hydrochloride oral solution - Arbor Pharmaceuticals; Sotylize

Latest Information Update: 02 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Arbor Pharmaceuticals
  • Class Antihypertensives; Class III antiarrhythmics; Ethanolamines
  • Mechanism of Action Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Atrial fibrillation; Atrial flutter; Ventricular arrhythmias

Most Recent Events

  • 23 Oct 2014 Registered for Atrial fibrillation in USA (PO)
  • 23 Oct 2014 Registered for Atrial flutter in USA (PO)
  • 23 Oct 2014 Registered for Ventricular arrhythmias in USA (PO) - First global approval
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top